Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Myocyte death in heart failure

P Anversa1, J Kajstura, G Olivetti

  • 1New York Medical College, Department of Medicine, Valhalla 10595, USA.

Current Opinion in Cardiology
|May 1, 1996
PubMed
Summary

Decompensated eccentric ventricular hypertrophy leads to heart failure, with myocyte loss driving cardiac dysfunction. Apoptosis significantly contributes to myocyte death in ischemic heart disease, but the role of fibrosis remains unclear.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Resident cardiac stem cells.

Current pharmaceutical design·2011
Same author

Role of stem cells in cardiovascular biology.

Journal of thrombosis and haemostasis : JTH·2011
Same author

Basic research and clinical applications of non-hematopoietic stem cells, 4-5 April 2008, Tubingen, Germany.

Cytotherapy·2009
Same author

The regenerative potential of the human heart.

International journal of cardiology·2004
Same author

Transgenic overexpression of insulin-like growth factor I prevents streptozotocin-induced cardiac contractile dysfunction and beta-adrenergic response in ventricular myocytes.

The Journal of endocrinology·2004
Same author

[Does apoptosis participate in heart failure?].

Cardiologia (Rome, Italy)·2002

Area of Science:

  • Cardiovascular Medicine
  • Cardiac Pathophysiology
  • Myocardial Remodeling

Background:

  • Decompensated eccentric ventricular hypertrophy signifies the progression from compensated overload to heart failure.
  • Myocyte loss, through apoptosis or necrosis, is a key factor in cardiac myopathy development.
  • Apoptotic cell death is more prevalent than necrosis in ischemic heart disease.

Purpose of the Study:

  • To investigate the role of myocyte loss in cardiac myopathy progression.
  • To understand the mechanisms of myocyte death (apoptosis vs. necrosis) in heart failure.
  • To determine if reactive fibrosis initiates or secondary to myocyte death.

Main Methods:

  • Analysis of cardiac tissue from patients with heart failure.
  • Histological examination to assess myocyte death and fibrosis.
  • Comparison of apoptotic and necrotic cell death markers.

Main Results:

  • Myocyte loss is a primary driver of ventricular wall thinning and chamber dilation.
  • Apoptosis is the predominant mode of myocyte death in ischemic cardiomyopathy.
  • The precise role of reactive fibrosis in initiating ventricular dysfunction requires further elucidation.

Conclusions:

  • Myocyte loss is central to the progression of cardiac myopathy.
  • Apoptosis plays a critical role in the pathogenesis of ischemic heart failure.
  • The relationship between fibrosis and myocyte death in heart failure warrants further investigation.

Related Experiment Videos